TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details






Profile for Ron Hall II, PharmD, MSCS

Ronald Hall

Ron Hall II, PharmD, MSCS

  • Associate Professor
Office Phone: 214-654-9404 ext 231
Email: Ronald.Hall@ttuhsc.edu
Mail Address: 5920 Forest Park Rd Ste 400
Dallas TX 75235-6418

Biography

Dr. Hall serves as the program director for the Dose Optimization and Outcomes Research (DOOR) progam. The DOOR program focuses on providing evidence to optimize the dosing and outcomes of medications for obese patients. Dr. Hall was selected as a National Institutes of Health Clinical Research Scholar in 2006. He was also the recipient of the 2008 Young Alumni Award from the St. Louis College of Pharmacy.

Research Interests

obesity, pharmacokinetics, antimicrobial, cancer, outcomes research

Selected Publications:

  • Payne KD, Hall RG. Dosing of antibacterial agents in obese adults: Does one size fit all?. Expert Rev Anti Infect Ther. 2014;12(7):829-54.
  • Alvarez CA, Giuliano CA, Haase KK, Thompson KA, Frei CR, Forcade NA, Brouse SD, Mortensen EM, Bell T, Bedimo RJ, Toups NM, Hall RG. Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia.. The American journal of the medical sciences. 2014.
  • Pusch T, Pasipanodya JG, Hall RG, Gumbo T. Therapy duration and long-term outcomes in extra-pulmonary tuberculosis.. BMC infectious diseases. 2014;14:115.
  • Hall RG, Swancutt MA, Meek CC, Leff RD, Gumbo T. Weight drives caspofungin variability in overweight and obese people: fractal power signatures beyond 2/3 or 3/4. Antimicrob Agents Chemother. 2013;57(5):2259-64.
  • Hall RG, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell TE, Bedimo RJ, Alvarez CA. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharmacology & Toxiciology. 2013;14:12.
©